1. Field of the Invention
The present invention relates to methods and apparatuses for culturing stem cell. More particularly, the present invention relates to methods and apparatuses for culturing stem cell using biomaterial shell, e.g. fertilized zebrafish chorions, which may induce formation of embryonic bodies, cell proliferation, and cell differentiation to other types effectively inside the chorions without adding any inducing agents or cell differentiation stimulants.
2. Description of the Related Art
Methods of stem cell culture in the related art are classified into two dominant methods. Specifically, those methods are classified depending on how to develop embryonic bodies. Hanging drop culture method (HDC method) using high viscosity and gravity of stem cell culture medium, the first method, is to collect stem cells from bottom part of droplet type stem cell medium hanging from certain structure. The second method called liquid suspension culture (LSC) method is to collect cells chemically in conventional cell culture dishes.
The first method is popular in current biology laboratory. The method is performed in a manner that the cells collected from the bottom part interact or transfer cellular signals to each other to form an embryonic body. To protect the drop, the droplet type stem cell medium, from natural evaporation inside an incubator, PBS (phosphate-buffered saline) solution is supplied continuously into the dishes located under the drops. Formation of an embryonic body requires two through four days for cellular adhesion. Accordingly, to grow a healthy embryonic body in a drop, tiny volume of fresh culture medium should be supplied frequently and the volume of each drop should be conserved during the supply of the fresh culture medium. However, it is quite difficult to handle the drops without changing its volume seriously or falling it to the ground.
The second method of the embryonic body formation is a chemical treatment of cells in the presence of 0.5%-1% DMSO (Dimethylsulfoxide) which also works as a cell differentiation stimulant later.
After the embryonic bodies are formed by either method, they should be transferred to hydrophilic environment, called tissue culture dish, for stable embryonic body attachment. However, during this cells delivery to new dishes, they are likely to suffer from various external contaminations, for example, contamination through frequent pipetting, and the optimum concentration for cell differentiation is not likely to be maintained. Therefore, it has been known that only about 10% of embryonic bodies can be differentiated successfully to the target cells. In addition, the two methods spend extravagant culture medium for the formation of tiny embryonic bodies, of which the diameter is just about 100-200 μm.
Except the two dominant methods, a microfluidic device with a built-in multiple-well structure and several flow-channels was introduced for stable medium supply and cell handling convenience. However, such a device is nothing more than a miniaturization of current culture dishes and no additional finction of biological purposes is included. Moreover, in current cell biotechnology or cell therapy, biological materials like extracellular matrix including gelatin, collagen, and etc. consisting of various glycoproteins, are preferable to biomaterial like PMMA (poly-methylmethacrylate) or PDMS (poly-dimethylsiloxane), because cells are basically familiar to that kind of materials than artificial polymers.
Accordingly, the present invention has been developed to solve the above mentioned problems occurring in the related art. The object of the present invention is to provide methods and apparatuses for culturing stem cell that develop embryonic bodies and promote stem cell differentiation with high efficiency without adding any chemical additives.
In order to accomplish the objects, there is provided an apparatus for culturing stem cell using biomaterial shell comprising: microwells for arrangement of the biomaterial shell; an inlet/outlet for supplying cell medium to the stem cell; and flow-channels for connecting the inlet/outlet to the microwells, and wherein the stem cell is encapsulated by the biomaterial shell.
Preferably, the biomaterial shell may have nano pore surface structure to allow the cell medium to flow into the biomaterial shell.
Preferably, the apparatus may further comprise microholes for preventing the biomaterial shell from falling into the flow-channels, diameter of the microholes being smaller than diameter of the microwells and the biomaterial shell.
Preferably, the apparatus may further comprise a cover layer for covering the microwells and the flow-channels to protect the stem cell from medium evaporation or external contaminations.
Preferably, the biomaterial shell may be fertilized chorion.
Preferably, the stem cell may be injected by micropipette into the biomaterial shell positioned in the microwell.
Preferably, the stem cell may be P19 embryonic carcinoma (P19EC).
Preferably, the apparatus may be loaded into CO2 incubator which contains 10% fetal bovine serum (FBS) to culture the stem cell encapsulated by the biomaterial shell.
Preferably, inner material of the biomaterial shell may be removed by injecting a jet of distilled water and ethanol through opening on the biomaterial shell.
In order to accomplish the objects, there is provided a method for culturing stem cell using biomaterial shell, comprising: injecting the stem cell into the biomaterial shell located in microwell; and loading the apparatus comprising the microwell into CO2 incubator which contains 10% fetal bovine serum (FBS) to culture the stem cell encapsulated by the biomaterial shell.
Preferably, the method may further comprise: supplying cell medium to the biomaterial shell by inputting the cell medium through inlet/outlet connected through flow-channel to the microwell.
Preferably, the biomaterial shell may have nano pore surface structure to allow cell medium to flow into the biomaterial shell.
Preferably, said injecting the stem cell into the biomaterial shell may comprise: making an opening on the biomaterial shell; and injecting a jet of distilled water and ethanol through the opening on the biomaterial shell.
Preferably, the stem cell may be P19 embryonic carcinoma (P19EC).
Preferably, the biomaterial shell may be fertilized chorion.
Preferably, the inner material of the fertilized chorion may be removed by injecting a jet of distilled water and ethanol through opening on the fertilized chorion.
Preferably, the chorions may function as the biomaterial-shell which encapsulates stem cell. For this, fertilized zebrafish eggs may be inserted into each microwell by using a pipette. Each chorion of the zebrafish eggs may have a specific nanopore structure with a dimension of 500-700 nm in diameter with 1.5-2.0 μm intervals. Thus, cell culture medium can flow freely into the chorion through the nanopore structure, while keeping cells relatively larger than each pore, inside the chorion.
Preferably, a micropipette may pierce the fertilized zebrafish chorion and make a tiny opening on its surface. A jet of distilled water may be injected into the chorion by a micropipette. Then, the jet of distilled water may destroy and exclude york and internal embryo mass outside the chorion.
Preferably, the empty chorion may be washed with the injection of ethanol and distilled water to biologically allowable level. The biologically allowable level may be defined as a level with no bacteria left behind after washing.
Preferably, mouse P19 embryonal carcinoma stem cell in culture medium may be injected by a micropipette through the same opening after the york and internal mass were removed.
In order to accomplish the objects, there is provided an apparatus for culturing stem cell using biomaterial shell, comprising: a microwell layer having a plurality of microwells; a microhole layer having a plurality of microholes, the microhole layer being located under the microwell layer, diameter of the microholes being smaller than diameter of the microwells and diameter of the biomaterial shell; and a flow-channel layer having a plurality of flow-channels for supplying cell medium to the microholes, the flow-channel layer being located under the microhole layer, and wherein the stem cell is encapsulated by the biomaterial shell in the microwell.
Preferably, the apparatus may further comprise an inlet/outlet connected to the flow-channel layer for supplying cell medium through the flow-channels to the microholes.
Preferably, the apparatus may further comprise a cover layer for covering the microwells and the flow-channels to protect the stem cell from medium evaporation or external contaminations.
Preferably, the apparatus is loaded into CO2 incubator which contains 10% fetal bovine serum (FBS) to culture the stem cell encapsulated by the biomaterial shell.
Preferably, the microhole layer may be manufactured by coating glass substrate with SU-8 photoresist, exposing the SU-8 photoresist layer to near UV, developing the SU-8 photoresist layer and separating the SU-8 photoresist layer from the glass substrate.
The above and other objects, features and advantages of the present invention will be more apparent from the following detailed description taken in conjunction with the accompanying drawings, in which:
Hereinafter, preferred embodiments of the present invention will be described with reference to the accompanying drawings. In the following description of the present invention, a detailed description of known functions and configurations incorporated herein will be omitted when it may make the subject matter of the present invention rather unclear.
Hereinafter, embryonic bodies developed by cross-adhesion between the P19 embryonic carcinoma (P19EC) stem cells will be referred to as “EBs.”
Before coating the glass substrate with the SU-8 photoresist, the glass substrate is cleaned by the piranha etch process (H2SO4:H2O2=4:1) (S11). Then, the glass surface is dehydrated and dried by baking process at 200° C. for 5 minutes on a hotplate. Then, the glass substrate is spin-coated with SU-8 photoresist (negative type, Microchem Corporation) at 3000 rpm to form a thin film (100 μm in thickness) thereon. Then, additional baking is done at 65° C. for 10 minutes and at 95° C. for 30 minutes on a hotplate (S12). To develop a cloned pattern, the coated photoresist is exposed to near UV (350-400 nm) for 21.5 seconds after aligning a mask with a micropattern over the photoresist. Post baking is done at 65° C. for 1 minute and at 95° C. for 10 minutes (S13). Then, the photoresist is developed using SU-8 developer for 10 minutes (S14). The patterned SU-8 layer is separated from the glass substrate by sonication process in deionized water for 30 seconds and immersion in IPA (2-propannoel) for 10 seconds (S15).
The four layers of the apparatus are assembled by stacking and bonding processes using UV curing epoxy 5. The stacking sequence is as follows; from the top, the cover layer (10), the microwell layer (20), the microhole layer (30), and the flow-channel layer (40). Bonding the layers is completed by UV radiation for 1 minute.
During procedures for EB growth, timely-scheduled cell lineages containing neural cells on the outer layer and beating cardiomyocytes inside EB are found; these are identified by using specific cell markers including nestin, MAP2b, GATA4 and cardiac troponin T (cTnT). As shown in
For more clear observations, the stem cells are marked by using several stem cell markers, including nestin and MAP2b for neural cells, and GATA-4 and cardiac troponin T (cTnT) for cardiac cell lineages. Both nestin and MAP2b can be found extensively outside the cell mass, whereas GATA-4 and cTnT are highly marked inside the cell mass. Thus, the morphological observations and expressions demonstrate that two major cell types differentiated within the chorion in the absence of any agents for cell differentiation are neural cell and cardiomyocyte lineages, respectively.
As described above, according to the present invention, it is made possible to perform embryonic body formation, cell proliferation and cell differentiation without additional agent including differentiation stimulants.